Ischemic heart disease
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Patients who underwent percutaneous coronary angioplasty for ischemic heart disease (2) Men and women aged 20 and over and under 85 (3) Patients who obtained written informed consent sign (4) Patients who can continue exercise therapy
Exclusion criteria
Exclusion criteria: (1) Patients with stroke less than 3 months after onset or systemic embolism (2) Patients with malignant tumor (patients whose symptoms have not been improved) (3) Patients whose prognosis is expected to be within one year due to other medical conditions (4) Others, patients who the research doctor judged as inappropriate for research
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Vascular function 9 months after onset of ischemic heart disease | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) Degree of coronary artery stenosis 9 months after onset of ischemic heart disease 2) Onset of cardiovascular and heart failure events 3) Changes in lipid markers and CPP 4) Adverse events, subjective symptoms | — |
Countries
Japan
Contacts
Jichi Medical University Division of Cardiovascular Medicine